Alex Wagner
Has grant
Associate Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
TOOLS FOR NORMALIZING AND INTERPRETING THE CLINICAL ACTIONABILITY OF GENOMIC VARIANTS
Open Date: 2019-06-01
Close Date: 2021-05-31
Grant: Close
A Collaborative Reporting Tool For Interpreting Genomic Events In Lung Cancers
Open Date: 2017-06-01
Close Date: 2019-05-31
Grant: Close
Bioinformatics Training in the Life Sciences and Biomedicine
Open Date: 2009-07-01
Close Date: 2014-06-30
Grant: Close
Molecular Oncology Training Grant
Open Date: 2005-09-01
Close Date: 2018-08-31
Grant: Close
Predoctoral Training Program in Genetics
Open Date: 1997-07-01
Close Date: 2022-06-30
Articles (9)
Year:
2026
Year:
2026
Categorical variants, or sets of genomic alterations constrained by shared properties, are pervasive across clinical, regulatory, and research domains in the biomedical ecosystem, yet their inconsistent and non-computable representation hinders data interoperability and clinical interpretation. We surveyed genomic knowledgebases spanning regulatory approvals and the biomedical literature and found that categorical variants underpin a substantial proportion of clinical genomics knowledge, but are largely described using incompatible bespoke models. To address this, we developed the GA4GH Categorical Variation Representation Specification (Cat-VRS), a constraint-based framework that provides a unified computable representation for both precise and intentionally broad categories across molecular and systemic variant domains. Cat-VRS enables harmonization of genomic knowledgebases, computable category-based search, and automated matching between assayed variants and categorical entities in clinical and research contexts. By providing a principled, extensible model for categorical variation, Cat-VRS enables computable reasoning over genomic variant categories and establishes a foundation for the standardized representation and exchange of genomic knowledge.
Year:
2026
Summary The druggable genome encompasses the genes that are known or predicted to interact with drugs. The Drug-Gene Interaction Database (DGIdb) provides an integrated resource for discovering and contextualizing these interactions, supporting a broad range of research and clinical applications. DGIdb is currently accessed through structured web interfaces and API calls, requiring users to translate natural-language questions into database-specific query patterns. To allow for the use of DGIdb through natural language, we developed the DGIdb Model Context Protocol (MCP) server, which allows large language models (LLMs) access to up-to-date information through the DGIdb API. We demonstrate that the MCP server greatly enhances an LLM’s ability to answer questions requiring accurate, up-to-date biomedical knowledge drawn from structured external resources. Availability and implementation The DGIdb MCP server is detailed at https://github.com/griffithlab/dgidb-mcp-server and includes instructions for accessing the server through the Claude desktop app.
Year:
2026
Interpreting genomic variation requires analysts to collate and process information from disparate genomic evidence resources to discern the contributions to diseases and drug responses. Differences in variant representation across these evidence repositories includes nomenclature (e.g., HGVS, SPDI), reference sequence context (e.g., GRCh37 or GRCh38 genome assemblies), sequence annotation sources (e.g., RefSeq or Ensembl), and aggregate variant concepts (e.g., canonical alleles) collectively make it difficult to reveal whether (and how) genomic variants are associated with clinical outcomes. We evaluated these challenges across established genomic knowledge resources, including content from the CIViC, Molecular Oncology Almanac, and ClinVar knowledgebases, as compared against real-world small variant and CNV data. We used these findings to develop a suite of variant normalization methods to address these gaps. We present our findings as well as an analysis of remaining gaps in the representation of variation data and recommendations for the continued development of genomic knowledge standards to address these gaps.
Year:
2025
Summary The Clinical Interpretation of Variants in Cancer (CIViC) knowledgebase provides a community-driven, open-source platform for discussing the biological and Clinical Significance of molecular variants in cancer. To enable users to make complex connections between CIViC information, we developed the CIViC Model Context Protocol (MCP) server, which allows large language models (LLMs) to directly interface with the CIViC API through natural language, facilitating the rapid summarization of expertly curated cancer variant interpretations. Availability and implementation The CIViC MCP server is detailed at https://github.com/griffithlab/civic-mcp-server with archived code and evaluation data deposited in Zenodo (DOI: 10.5281/zenodo.17344050). The repository is a fork of https://github.com/QuentinCody/civic-mcp-server (QuentinCody 2025) and includes instructions for accessing the server through the Claude desktop app and hosting it locally with GPT-5. We also provide a Python script for directly querying the MCP server. Supplemental information Supplementary data are available at Bioinformatics online.
Year:
2025
Reference genomes are foundational to genomics but suffer from widespread ambiguity and incompatibility due to inconsistent naming, undocumented differences, and lack of formal mechanisms for comparison. To address this, we introduce the GA4GH refget Sequence Collections (seqcol) standard. Refget seqcol is a framework for unambiguous representation, retrieval, and comparison of sequence collections such as reference genomes and transcriptomes. The seqcol standard comprises four components: a structured data schema, a canonical encoding algorithm that produces content-based, globally unique identifiers, a retrieval API, and a comparison protocol. This standard enables precise identification of sequence collections, even across decentralized or private systems, and allows compatibility assessments beyond exact identity, such as order-relaxed matches or shared coordinate systems. We applied the refget seqcol standard to 60 human and 36 mouse reference genomes sourced from major providers. Using digest-based comparisons, we quantified levels of similarity across attributes including sequence names, lengths, coordinate systems, and actual sequence content. Our analysis revealed some consistent subsets of sequences or coordinate systems, as well as substantial incompatibility among references and duplicate references under different names. To support adoption of refget seqcol, we provide a Python package implementing the full standard, a web API, and a comparison interface allowing users to assess local references against a curated database. This work offers a scalable, reproducible solution to the reference genome compatibility crisis, enabling improved transparency, reuse, and integration in genomic analyses. Refget seqcol enhances interoperability across tools and datasets, making genomic research more robust and reproducible.
Year:
2025
Background The Human Genome Variation Society (HGVS) Nomenclature is the global standard for describing and communicating variants in DNA, RNA, and protein sequences in clinical and research genomics. This manuscript details recent updates to the HGVS Nomenclature, highlighting improvements in governance, community engagement, website functionality, and underlying implementation of the standard. Methods The HGVS Variant Nomenclature Committee (HVNC) now operates under the Human Genome Organization (HUGO), facilitating broader community feedback and collaboration with related standards organizations. The website has been redesigned using modern documentation tools and practices. The specification was updated to include guidance for transcript selection and to align with recent cross-consortia recommendations for the representation of gene fusions. A formal computational grammar was introduced to improve the precision and consistency of variant descriptions. Results Major improvements in HGVS Nomenclature v. 21.1 include a redesigned website with enhanced navigation, search functionality, and mobile responsiveness; a new versioning policy aligned with software management practices; formal mechanisms for community feedback and change proposals; and adoption of Extended Backus-Naur Form (EBNF) for defining syntax. The specification now recommends MANE Select transcripts where appropriate and includes updated guidance for representing adjoined transcripts and gene fusions. All content is freely available under permissive licenses at hgvs-nomenclature.org. Conclusions These advancements establish a more sustainable foundation for maintaining and evolving the HGVS Nomenclature while improving its accessibility and utility. The introduction of formal computational grammar marks a crucial step toward unambiguous variant descriptions that can be reliably processed by both humans and machines. Combined with enhanced community engagement mechanisms and improved guidance, these changes position the HGVS Nomenclature to better serve the evolving needs of clinical and research genomics while maintaining the stability that users require.
Year:
2024
Year:
2023
Collaborators (10)
Oliver Hofmann
Associate Professor
University of Melbourne
Obi Griffith
Professor
Washington University in St. Louis
Nathan Sheffield
Professor
University of Virginia
Kilannin Krysiak
Associate Professor
Washington University in St. Louis
Eliezer Van Allen
Professor
Harvard University
Susanna Kiwala
Washington University in St. Louis
Jeroen F J Laros
Leiden University Medical Center
Michael Love
Associate Professor
University of North Carolina at Chapel Hill
Ivo Fokkema
Leiden University Medical Center
Malachi Griffith
Professor
Washington University in St. Louis
Make your next move.
Prepare your application
Review drafts before you send them.